Recent Quarter Total Invested
$314.26 M
Recent Quarter Institutional Ownership Percentage
108.12%
Total Invested of Last Quarter
$1.34 B
Ownership Percentage of Last Quarter
120.07%
Zentalis Pharmaceuticals, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| MATRIX CAPITAL MANAGEMENT COMPANY, LP | 08/14/2024 | 13.96 M | $57.10 M | 0.00% | 19.69% |
| FMR LLC | 08/13/2024 | 8.68 M | $35.49 M | -18.48% | 12.24% |
| EVENTIDE ASSET MANAGEMENT, LLC | 08/13/2024 | 8.55 M | $34.96 M | -26.15% | 12.06% |
| VANGUARD GROUP INC | 08/13/2024 | 5.65 M | $23.13 M | 28.56% | 7.98% |
| BLACKROCK INC. | 08/13/2024 | 4.82 M | $19.71 M | 3.72% | 6.80% |
| CITADEL ADVISORS LLC | 08/14/2024 | 4.50 M | $18.42 M | 16.89% | 6.35% |
| DECHENG CAPITAL LLC | 08/14/2024 | 3.07 M | $12.56 M | 46.24% | 4.33% |
| STATE STREET CORP | 08/14/2024 | 3.05 M | $12.48 M | -19.37% | 4.31% |
| MORGAN STANLEY | 10/17/2024 | 1.95 M | $7.98 M | 88.04% | 2.75% |
| WOODLINE PARTNERS LP | 08/14/2024 | 1.52 M | $6.20 M | 5.57% | 2.14% |
| BIOIMPACT CAPITAL LLC | 08/14/2024 | 1.45 M | $5.93 M | -4.37% | 2.05% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/09/2024 | 1.33 M | $5.46 M | 2.47% | 1.88% |
| T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 08/14/2024 | 1.33 M | $5.42 M | -60.06% | 1.87% |
| PRIMECAP MANAGEMENT CO/CA/ | 08/09/2024 | 1.23 M | $5.04 M | 5.82% | 1.74% |
| TWO SIGMA INVESTMENTS, LP | 08/14/2024 | 1.05 M | $4.30 M | 329.56% | 1.48% |
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 08/14/2024 | 961,486 | $3.93 M | 0.00% | 1.36% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 08/14/2024 | 923,901 | $3.78 M | -73.53% | 1.30% |
| TWO SIGMA ADVISERS, LP | 08/14/2024 | 796,900 | $3.26 M | 689.01% | 1.12% |
| CAPITAL INTERNATIONAL INVESTORS | 08/13/2024 | 675,371 | $2.76 M | -76.05% | 0.95% |
| RENAISSANCE TECHNOLOGIES LLC | 08/09/2024 | 661,682 | $2.71 M | 152.61% | 0.93% |
| DIMENSIONAL FUND ADVISORS LP | 08/09/2024 | 626,663 | $2.56 M | -13.40% | 0.88% |
| GOLDMAN SACHS GROUP INC | 08/13/2024 | 619,253 | $2.53 M | 86.52% | 0.87% |
| VERITION FUND MANAGEMENT LLC | 08/14/2024 | 552,820 | $2.26 M | -52.15% | 0.78% |
| BANK OF AMERICA CORP /DE/ | 08/14/2024 | 508,233 | $2.08 M | 6.78% | 0.72% |
| JPMORGAN CHASE & CO | 08/12/2024 | 495,810 | $2.03 M | 745.79% | 0.70% |
| NORTHERN TRUST CORP | 08/14/2024 | 495,266 | $2.03 M | -5.43% | 0.70% |
| 5AM VENTURE MANAGEMENT, LLC | 08/14/2024 | 490,000 | $2.00 M | 0.00% | 0.69% |
| FEDERATED HERMES, INC. | 08/08/2024 | 482,481 | $1.97 M | -75.86% | 0.68% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 08/12/2024 | 468,413 | $1.92 M | 2.74% | 0.66% |
| BOXER CAPITAL, LLC | 08/14/2024 | 450,000 | $1.84 M | 0.00% | 0.63% |
| MILLENNIUM MANAGEMENT LLC | 08/14/2024 | 392,608 | $1.61 M | 59.39% | 0.55% |
| BANK OF NEW YORK MELLON CORP | 07/25/2024 | 333,719 | $1.36 M | 15.12% | 0.47% |
| GSA CAPITAL PARTNERS LLP | 08/15/2024 | 255,201 | $1.04 M | 2,307.10% | 0.36% |
| D. E. SHAW & CO., INC. | 08/14/2024 | 240,341 | $982,995 | 1,581.76% | 0.34% |
| MAYO CLINIC | 08/12/2024 | 187,143 | $765,415 | 0.00% | 0.26% |
| XTX TOPCO LTD | 08/12/2024 | 178,465 | $729,922 | 1,581.89% | 0.25% |
| JANE STREET GROUP, LLC | 08/15/2024 | 172,989 | $707,525 | 39.19% | 0.24% |
| RAFFERTY ASSET MANAGEMENT, LLC | 08/13/2024 | 167,564 | $685,337 | -43.77% | 0.24% |
| SQUAREPOINT OPS LLC | 08/14/2024 | 148,755 | $608,408 | 543.79% | 0.21% |
| NUVEEN ASSET MANAGEMENT, LLC | 08/09/2024 | 130,308 | $532,959 | 0.00% | 0.18% |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | 08/14/2024 | 129,129 | $528,138 | -2.04% | 0.18% |
| UBS ASSET MANAGEMENT AMERICAS INC | 08/14/2024 | 113,386 | $463,749 | 68.05% | 0.16% |
| ALLIANCEBERNSTEIN L.P. | 08/14/2024 | 110,738 | $452,918 | 91.86% | 0.16% |
| UBS GROUP AG | 08/14/2024 | 107,100 | $438,039 | -60.02% | 0.15% |
| SWISS NATIONAL BANK | 08/08/2024 | 104,700 | $428,223 | 7.49% | 0.15% |
| Y-INTERCEPT (HONG KONG) LTD | 08/14/2024 | 103,916 | $425,016 | 100.00% | 0.15% |
| TD ASSET MANAGEMENT INC | 08/02/2024 | 102,880 | $420,779 | -60.25% | 0.15% |
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 08/09/2024 | 101,270 | $414,194 | 420.11% | 0.14% |
| BANK OF MONTREAL /CAN/ | 08/14/2024 | 98,331 | $1.13 M | 100.00% | 0.14% |
| RHUMBLINE ADVISERS | 08/01/2024 | 94,213 | $385,319 | 13.84% | 0.13% |
Zentalis Pharmaceuticals, Inc.institutional Ownership - Frequently Asked Questions
-
Who are the largest shareholders of ZNTL shares?
During the previous two years, 170 institutional investors and hedge funds held shares of Zentalis Pharmaceuticals, Inc.. The most heavily invested institutionals were:
Matrix Capital Management Company, LP: 13.96 M
EVENTIDE ASSET MANAGEMENT, LLC: 8.55 M
BlackRock Funding, Inc. /DE: 4.76 M
Decheng Capital LLC: 3.11 M
CITADEL ADVISORS LLC: 2.72 M
MORGAN STANLEY: 1.61 M
-
What percentage of Zentalis Pharmaceuticals, Inc. stock is owned by institutional investors?
108.12% of Zentalis Pharmaceuticals, Inc. stock is owned by institutional investors.
-
How much institutional buying is happening at ZNTL ?
Institutional investors have bought a total of 67.44 M shares in the last 24 months. This purchase volume represents approximately $217.83 M in transactions.